Analysis of Accurate Real World Data to Support Informed Strategic Decisions
Vector Oncology’s HEOR/HOPE business line, created in 2005, conducts studies involving health outcomes and economic endpoints, including prospective observational research, cross-sectional survey studies, and retrospective studies utilizing our aggregated data. Our Data Warehouse is a repository of electronic medical records, billing data, and patient-reported outcome data from geographically diverse community oncology practices.
Our team has many years of oncology research experience with an exceptional understanding of oncology specific treatment delivery models. Vector Oncology provides gold standard quality data drawn directly from electronic medical records and billing systems in community oncology practices. This data includes physician progression notes and other text documents that provide detail critical to accurate classification and analysis in many research studies. Augmenting the structured data by mining the unstructured data is an established process that increases the value of our approach.
Ability to Conduct Patient Centered Research
The Data Warehouse contains clinical data regarding patients seen over the past decade across diverse community oncology practices. Our warehouse includes a repository of Patient Care Monitor™ (PCM) records, a patient reported inventory of symptoms experienced by the patient. Our health economics and outcomes team is then able to examine patient reported outcomes as part of retrospective and prospective research.
Our established relationships with many practices that have participated in patient survey research allow us to answer research questions ranging from patient financial concerns to management of treatment side effects, to the patients willingness to pay for supportive care that may reduce treatment side effects. These research methods are utilized in Cross-sectional studies.
Vector Oncology has the capability for prospective observational studies that collect patient-reported outcomes during and following treatment at defined intervals. As a real world research team with over a decade of experience, we have direct access to experienced experts across a wide range of clinical operations activities.